New chemo delivery method shows promise for tough mesothelioma cases

NCT ID NCT02611037

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to deliver chemotherapy directly to the tumor in adults with malignant pleural mesothelioma that cannot be removed by surgery. The treatment, called transarterial chemoperfusion, uses a combination of three drugs (cisplatin, methotrexate, and gemcitabine) to control the disease. The goal was to see if this approach is safe and effective at stopping the cancer from growing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • H. Lee Moffitt Cancer Center and Research Institute

    Tampa, Florida, 22612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.